Edit |   |
---|---|
Antigenic Specificity | HBV, Human (Lenvervimab biosimilar) |
Clone | Lenvervimab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human HBV Recombinant Antibody (Lenvervimab). Lenvervimab (INN, development code GC1102) is a monoclonal antibody that is being investigated for hepatitis B. This drug is being developed by GC Pharma. As of 2018, lenvervimab is undergoing Phase II/III trials. |
Immunogen | n/a |
Other Names | Anti-HBV Recombinant Antibody, Research Grade Lenvervimab, Anti-Human HBV Recombinant Antibody(Lenvervimab), GC-1102, Antibody Drug Analogues, Monoclonal Antibody, YR1501, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 2055006-79-4 |
Catalog # | YR1501 |
Price | please inquire |
Order / More Info | HBV, Human (Lenvervimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |